| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.003 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.007 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.009 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |